This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias
Search

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Adverse event reporting can be found at the bottom of the page

Menu

Close

DiagnosisImpactPatient ViewIndividualised
treatment
PathophysiologyCase-based learningSupporting ResourcesMaterialsVideosEventsOnline Learning

Click here for Vydura® (rimegepant) Prescribing Information for Great Britain and Northern Ireland.
Adverse event reporting information can be found at the bottom of the page.

logoFocus on the person A guide to supporting people with migraine
Optimal management of a person with migraine has the potential to transform their life, as well as reduce pressure on healthcare services and provide wider benefits to society and the economy.1 With migraine affecting one in seven adults in the UK,1 we probably all know someone with migraine.
Whom do you know with migraine?

When someone else’s daughter, sister, husband or friend presents with migraine at your practice, what impact can you make on their life?

Follow the journey below to learn about different aspects of patient-centric migraine care.
Complete the final case-based learning page to check your knowledge.
What a headache!

Unpicking headache classification, recognising red flag symptoms and identifying indicators for referral

A broad impact

Appreciating the wide-reaching effect of migraine on individuals, families, the NHS and society as a whole

Through the eyes of the patient

Recognising the different needs, preferences and treatment goals of individuals with migraine

Treating the individual

Understanding appropriate treatment options and how to provide personalised care

The mechanism of migraine

Unravelling the pathophysiology of migraine and the mechanism of action of migraine drugs

Case-based learning

Assess your awareness of patient‑centric management of migraine

What a headache!

Unpicking headache classification, recognising red flag symptoms and identifying indicators for referral

A broad impact

Appreciating the wide-reaching effect of migraine on individuals, families, the NHS and society as a whole

Through the eyes of the patient

Recognising the different needs, preferences and treatment goals of individuals with migraine

Treating the individual

Understanding appropriate treatment options and how to provide personalised care

The mechanism of migraine

Unravelling the pathophysiology of migraine and the mechanism of action of migraine drugs

Case-based learning

Assess your awareness of patient-centric management of migraine

Reference

The Migraine Trust. State of the migraine nation. Dismissed for too long, 2021. Available at: migrainetrust.org. Accessed August 2022
PP-NNT-GBR-0090. November 2022

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2024 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-7866. January 2024
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-7812. January 2024

YesNo
You are now leaving PfizerPro​​​​​

​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​